V-Citrus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 2 Year, 1 Month
About V-Citrus Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anand Madhavan, Janardhanam Sethuraman, and Parthasarathy Padmini serve as directors at the Company.
- CIN/LLPIN
U24290TN2022PTC156367
- Company No.
156367
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2022
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at V-Citrus Pharmaceuticals?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anand Madhavan | Director | 01-Nov-2022 | Current |
Janardhanam Sethuraman | Director | 01-Nov-2022 | Current |
Parthasarathy Padmini | Director | 01-Nov-2022 | Current |
Financial Performance and Corporate Structure Insights of V-Citrus Pharmaceuticals.
Enhance accessibility to V-Citrus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of V-Citrus Pharmaceuticals?
Unlock access to V-Citrus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Nortels Service Apartments Private LimitedActive 24 years 5 months
Janardhanam Sethuraman is a mutual person
- Mahabalipuram Mamalla Hotels & Resorts LlpActive 1 year 8 months
Janardhanam Sethuraman is a mutual person
- Aims-Aviation Infrastructure Services Private LimitedActive 5 years 4 months
Parthasarathy Padmini is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at V-Citrus Pharmaceuticals?
V-Citrus Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of V-Citrus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped V-Citrus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.